---
$id: https://graph.org.ai/products/commodity/51142509
$type: Product
source: UNSPSC
code: "51142509"
title: "Ropinirole"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ropinirole

**UNSPSC Code**: 51142509
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiparkinsonian agent with the molecular formula C16H24N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 030PYR8953, chemically known as 4-(2-dipropylaminoethyl)-1,3-dihydroindol-2-one but generally known as ropinirole, which bears US NIH Compound Identifier 5095. European Medicines Agency schedules Ropinirole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10380MIG. The term ROPINIROLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules ropinirole in its Anatomical Therapeutic Chemical (ATC) Classification. ROPINIROLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ropinirole under HS 29337900 and SITC 51561. As of Q4 2014, ROPINIROLE remains the US FDA Preferred Term for this commodity. Ropinirole bears US NLM identifiers UMLS ID C0244821 and NCI Concept Code C61931. SMILES: O=C1NC2C(C(CCN(CCC)CCC)CCC2)C1.

